|
Delayed
Nasdaq
20:45:43 19/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.000 USD | +0.43% |
|
+13.45% | +4.67% |
| 08-12 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.43% | +13.45% | +14.57% | +39.72% | +4.67% | +43.74% | -83.17% | -91.60% | -73.28% | 31.73M | ||
| +4.25% | +1.58% | +16.40% | +36.78% | +5.71% | +22.92% | +15.08% | +10.99% | +298.83% | 218B | ||
| +5.79% | +2.17% | +4.55% | +25.87% | -8.15% | -0.92% | -15.96% | -34.25% | +160.41% | 140B | ||
| +2.28% | -0.21% | +13.38% | -9.32% | -29.30% | -16.44% | +39.68% | +13.80% | +424.07% | 138B | ||
| +3.75% | +1.68% | +19.45% | -7.97% | -45.17% | -49.60% | +3.70% | +18.10% | +116.32% | 73.14B | ||
| +1.35% | -1.06% | +8.31% | +12.05% | +7.99% | +16.63% | +20.61% | -21.95% | +133.91% | 52.44B | ||
| +1.32% | +2.43% | +13.10% | +18.07% | -11.00% | -16.15% | -12.09% | -33.12% | - | 50.85B | ||
| +4.27% | +4.26% | +18.65% | +39.78% | +13.58% | +28.68% | +30.03% | -7.82% | +224.56% | 41.92B | ||
| +3.82% | -0.28% | +16.07% | +24.52% | +9.25% | +39.39% | +55.32% | +2.50% | +158.94% | 39.42B | ||
| +2.61% | +3.15% | +18.67% | +21.08% | -9.10% | +0.80% | +8.10% | - | - | 32.81B | ||
| +4.32% | +1.50% | +15.49% | +10.40% | -4.77% | -19.81% | +38.27% | -18.96% | +227.36% | 31.73B | ||
| +7.50% | +5.21% | +9.90% | +43.25% | +54.74% | +99.76% | +21.23% | -56.85% | +18.22% | 28.43B | ||
| +0.05% | -1.86% | +0.80% | -3.65% | -20.91% | -36.35% | -44.58% | -56.62% | - | 27B | ||
| +0.43% | +1.72% | -0.30% | +4.52% | +1.51% | -0.55% | +18.31% | -32.45% | +1.55% | 26.58B | ||
| +0.73% | +1.57% | +20.32% | +22.22% | +7.41% | +21.00% | +18.25% | -4.89% | +166.44% | 14.09B | ||
| +4.78% | +1.26% | +12.15% | +24.51% | +23.38% | +30.57% | +4.81% | -34.33% | +115.86% | 12.69B | ||
| +3.03% | -0.74% | +4.74% | +38.13% | +24.88% | +68.86% | -5.60% | -29.75% | +167.04% | 8.66B | ||
| -3.60% | -13.15% | +0.70% | -11.51% | -23.57% | -19.67% | - | - | - | 4.11B | ||
| -9.09% | -14.48% | +14.96% | +6.48% | - | - | - | - | - | 4.14B | ||
| +0.01% | +0.01% | +30.18% | +38.31% | +59.49% | +17.71% | +48.09% | +29.03% | +463.72% | 4.25B | ||
| Average | +1.88% | -1.71% | +12.60% | +18.66% | +3.19% | +12.14% | +8.89% | -20.48% | +173.60% | 47.43B | |
| Weighted average by Cap. | +3.44% | -2.30% | +12.73% | +18.27% | -5.40% | +4.54% | +13.34% | -8.26% | +231.90% |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
















